Copy to clipboard 
Nextremity Solutions expanded its Nextra® Hammertoe System family to provide additional treatment options for surgeons.
The original Nextra Hammertoe System launched in 2012 and was one of the first two-piece, fully reversible, hammertoe options available in the marketplace. While the success of the Nextra Hammertoe proved the need for a two-piece hammertoe system, there was still a demand for a system that allowed for K-wires to be used to assist in the placement of the implants.
This would require Nextremity Solutions to develop a two-piece cannulated hammertoe system. In 2020, Nextremity Solutions received 510(k) clearance for the Nextra CH Cannulated Hammertoe System. This system provided surgeons an additional two-piece option for the treatment of hammertoe deformity and met the demand to have a system that could utilize K-wires for additional stability and for stabilizing the lesser MTP joints.
In September 2021, Nextremity Solutions received another 510(k) clearance for the Nextra PEEK Hammertoe System. This two-piece, non-cannulated system is made of a material known as polyetheretherketone (PEEK). This material is radiolucent, allowing surgeons better visibility of the joint post-surgery. This visibility can help surgeons determine the progression of joint fusion and healing in the patient.
The Nextra Hammertoe Correction System, Nextra CH Hammertoe Correction System and Nextra PEEK Hammertoe Correction System are indicated for small bone reconstruction limited to interphalangeal repair and fusion of the lesser toes.
Source: Nextremity Solutions, Inc.
Nextremity Solutions expanded its Nextra® Hammertoe System family to provide additional treatment options for surgeons.
The original Nextra Hammertoe System launched in 2012 and was one of the first two-piece, fully reversible, hammertoe options available in the marketplace. While the success of the Nextra Hammertoe proved the need for a...
Nextremity Solutions expanded its Nextra® Hammertoe System family to provide additional treatment options for surgeons.
The original Nextra Hammertoe System launched in 2012 and was one of the first two-piece, fully reversible, hammertoe options available in the marketplace. While the success of the Nextra Hammertoe proved the need for a two-piece hammertoe system, there was still a demand for a system that allowed for K-wires to be used to assist in the placement of the implants.
This would require Nextremity Solutions to develop a two-piece cannulated hammertoe system. In 2020, Nextremity Solutions received 510(k) clearance for the Nextra CH Cannulated Hammertoe System. This system provided surgeons an additional two-piece option for the treatment of hammertoe deformity and met the demand to have a system that could utilize K-wires for additional stability and for stabilizing the lesser MTP joints.
In September 2021, Nextremity Solutions received another 510(k) clearance for the Nextra PEEK Hammertoe System. This two-piece, non-cannulated system is made of a material known as polyetheretherketone (PEEK). This material is radiolucent, allowing surgeons better visibility of the joint post-surgery. This visibility can help surgeons determine the progression of joint fusion and healing in the patient.
The Nextra Hammertoe Correction System, Nextra CH Hammertoe Correction System and Nextra PEEK Hammertoe Correction System are indicated for small bone reconstruction limited to interphalangeal repair and fusion of the lesser toes.
Source: Nextremity Solutions, Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
